Physician profile
Ankit Mehra
NPI 1386807337
$2,931.24
in general payments reported to CMS, 2019-2025
20 companies · $281 in 2025
The $281 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $191 · 2021: $42.92 · 2022: $408 · 2023: $309 · 2024: $1,141 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,731.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $813.96 | 2019-2024 | Agilis Hispro, Aveir |
| Irhythm Technologies, INC. | $351.53 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Amgen INC. | $326.21 | 2022-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $240.92 | 2019-2024 | Lifevest |
| Teleflex LLC | $240.02 | 2024 | Manta |
| Boston Scientific Corporation | $223.96 | 2019-2025 | Emerge Push |
| Novartis Pharmaceuticals Corporation | $190.35 | 2019-2025 | |
| Pfizer INC. | $122.92 | 2023-2025 | |
| Medtronic, INC. | $91.82 | 2023 | Linq II |
| Cardiovascular Systems INC. | $52.29 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $41.43 | 2019 | |
| Merck Sharp & Dohme LLC | $37.53 | 2022-2023 | Verquvo |
| Preventice Services, LLC | $31.69 | 2021 | |
| Zoll Circulation INC | $28.77 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $28.09 | 2022-2025 | Farxiga |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $27.34 | 2021-2024 | Xarelto |
| Lilly USA, LLC | $23.92 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.75 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.96 | 2024 | Camzyos |
| Medtronic Vascular, INC. | $16.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankit Mehra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.